IPP Bureau
Bafna Pharmaceuticals inaugurates Quality Control Lab
By IPP Bureau - April 28, 2024
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
Apollo HealthCo to raise Rs. 2,475 crore from Advent International
By IPP Bureau - April 28, 2024
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Zydus receives final approval from USFDA for Tretinoin Cream
By IPP Bureau - April 28, 2024
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Evonik expands capacity for customized Resomer powder biomaterials
By IPP Bureau - April 28, 2024
New solvent-free micronization technology expanded at the Darmstadt site in Germany
CHMP adopts positive opinion recommending approval of Bristol Myers Squibb’s Opdivo in combination with Cisplatin and Gemcitabine
By IPP Bureau - April 27, 2024
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
AstraZeneca 1Q 2024 revenue up 19% to US$ 12,679 million
By IPP Bureau - April 27, 2024
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Takeda receives positive CHMP opinion for Fruquintinib in previously treated mCRC
By IPP Bureau - April 27, 2024
If approved in the European Union, Fruquintinib will be the first novel targeted therapy for Metastatic Colorectal Cancer regardless of biomarker status in over a decade
FDA approves Biktarvy label update with data for pregnant adults with HIV
By IPP Bureau - April 27, 2024
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
Divi's Laboratories to expand capacity at an outlay of approx. Rs. 700 Cr
By IPP Bureau - April 26, 2024
The proposed facility is expected to be operational around January, 2027
Dr. Reddy's and Nestle India to form JV for health science nutraceutical portfolio
By IPP Bureau - April 26, 2024
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
By IPP Bureau - April 26, 2024
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Merck 1Q 2024 sales up 9% to US$ 15.8 billion
By IPP Bureau - April 26, 2024
Sales reflect continued strong growth in oncology and vaccines
Syngene International reports Q4 FY24 consolidated PAT at Rs. 188.6 Cr
By IPP Bureau - April 25, 2024
Syngene International has reported total income of Rs. 933 crores during the period ended March 31, 2024
Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility
By IPP Bureau - April 25, 2024
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
New chemical method could cut waste from drug production
By IPP Bureau - April 25, 2024
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
